Solid Bio's DMD gene therapy graduates from partial FDA hold to full-on clinical hold

Solid Bio's DMD gene therapy graduates from partial FDA hold to full-on clinical hold

Submitted by admin on March 14, 2018 - 9:29pm
Source: 
Fierce Biotech
News Tags: 
Solid Biosciences
gene therapy
FDA
DMD
Duchenne Muscular Dystrophy
Headline: 
Solid Bio's DMD gene therapy graduates from partial FDA hold to full-on clinical hold

Do Not Allow Advertisers to Use My Personal information